Bid Price | 210.00p | High Price | 211.00p |
---|
Ask Price | 220.00p | Low Price | 210.00p |
---|
Open Price | 215.00p | Spread | 4.55% |
---|
Prev Close | 215.00p | Volume | 7,958 |
---|
Faron Pharmaceuticals Oy Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jul 4, 2025 | 215.00 | 211.00 | 210.00 | 215.00 | 7,958 |
Jul 3, 2025 | 215.00 | 220.00 | 212.50 | 215.00 | 2,753 |
Jul 2, 2025 | 202.50 | 220.00 | 208.90 | 215.00 | 6,116 |
Jul 1, 2025 | 202.50 | 209.00 | 197.15 | 202.50 | 2,924 |
Jun 30, 2025 | 190.00 | 205.00 | 190.00 | 202.50 | 49,561 |
More Faron Pharmaceuticals Oy Historic Prices >Faron Pharmaceuticals Oy Information
Name | Faron Pharmaceuticals Oy | Index | FTSE AIM 100 |
---|
ISIN | FI4000153309 | Epic | FARN |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 750 | Trading Status | Closed |
---|
Shares in Issue | 116.95 m | Prev Close | 215.00p |
---|
PE Ratio | | Market Cap | £251.45 m |
---|
Div Yield | 0 | Div per Share | €NaN |
---|
EPS | -€0.09 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 1.087897 | Quick Ratio | 0.954085 |
---|
Faron Pharmaceuticals Oy Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
30/06/25 | BUY | Juho Jalkanen | RES | 2,000 @ €2.27 | €4,540.00 |
30/06/25 | BUY | Juho Jalkanen | RES | 22,127 @ €2.26 | €50,007.00 |
05/06/25 | SELL | Markku Jalkanen | CEO | 100,000 @ €3.00 | €300,390.00 |
05/06/25 | TOUT | Markku Jalkanen | CEO | 100,000 @ €0.00 | €0.00 |
05/06/25 | SELL | Markku Jalkanen | CEO | 200,000 @ €3.10 | €619,632.00 |
05/06/25 | TOUT | Markku Jalkanen | CEO | 400,000 @ €0.00 | €0.00 |
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Yrjo Wichmann | RES | 2,333 @ £0.00 | £0.00 |
24/06/24 | TIN | Tuomo Patsi | NED | 6,667 @ £0.00 | £0.00 |
More Faron Pharmaceuticals Oy Director Deals >Faron Pharmaceuticals Oy News